Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
how do you manage atypical adenomatous hyperplasia (AAH) at the margin for 2 sites of the same lobe, in a patient with multiple GGO's s/p wedge resection?
Related Questions
How do you assess whether a patient will be a good DIBH candidate for lung or abdomen treatments?
How would you approach an in-field recurrence after lung SBRT for a T1 NSCLC in a patient with poor underlying lung function?
How do you construct your target volumes for superior sulcus tumors?
Do you offer adjuvant durvalumab for stage I small cell lung cancer following SBRT or surgery?
How are you incorporating Tumor Treating Fields for locally progressive/metastatic NSCLC, if at all?
How would you treat a patient with newly diagnosed ALK+ Stage IIIB non-small cell lung cancer (NSCLC)?
Do you restrict the dose rate during treatment delivery to a pacemaker in addition to limiting the Dmax?
What constraints do you use for the BID small cell lung cancer regimen?
Do you recommend consolidation immunotherapy after SBRT or surgery and chemo for T1-T2N0 SCLC?
Did NRG LU004 demonstrate safety with hypofractionated lung radiation and concurrent ICI?
